1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DPM1 CTRPv2 pan-cancer AAC -0.17 1e-06
mRNA AHNAK CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA NBPF10 CTRPv2 pan-cancer AAC -0.17 1e-06
mRNA NFS1 CTRPv2 pan-cancer AAC -0.17 1e-06
mRNA TRPV2 CTRPv2 pan-cancer AAC -0.17 0.0001
mRNA RAB1A CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA SLC12A4 CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA ASAP2 CTRPv2 pan-cancer AAC -0.17 7e-05
mRNA SYDE1 CTRPv2 pan-cancer AAC -0.17 0.0002
mRNA ARHGAP12 CTRPv2 pan-cancer AAC -0.17 5e-05
Download CSV